about
A genome-wide comparative evolutionary analysis of herpes simplex virus type 1 and varicella zoster virus.Anti-glycoprotein g antibodies of herpes simplex virus 2 contribute to complete protection after vaccination in mice and induce antibody-dependent cellular cytotoxicity and complement-mediated cytolysisRad51 and Rad52 are involved in homologous recombination of replicating herpes simplex virus DNA.Secreted portion of glycoprotein g of herpes simplex virus type 2 is a novel antigen for type-discriminating serologyPhylogenetic analysis of clinical herpes simplex virus type 1 isolates identified three genetic groups and recombinant virusesTyping of clinical herpes simplex virus type 1 and type 2 isolates with monoclonal antibodies.Herpes simplex virus types 1 and 2 differ in their interaction with heparan sulfate.Use of a fragment of glycoprotein G-2 produced in the baculovirus expression system for detecting herpes simplex virus type 2-specific antibodies.Novel rat models to study primary genital herpes simplex virus-2 infection.CD4(+) T-cell responses to herpes simplex virus type 2 (HSV-2) glycoprotein G are type specific and differ in symptomatic and asymptomatic HSV-2-infected individuals.Occurrence of angina pectoris prior to acute myocardial infarction and its relation to prognosis.Failure to demonstrate enterovirus aetiology in Swedish patients with dilated cardiomyopathyEarly identification of acute myocardial infarction and prognosis in relation to mode of transport to hospitalTorsade de pointes tachycardias induced by overdosage of zimeldineEmergency room prediction of mortality and severe complications in patients with suspected acute myocardial infarction
P50
Q31028221-14A16F43-B4A3-4057-B16F-DB6472B2956FQ34580831-D1E5F419-DC33-4C28-92F5-36113A119DC4Q35387821-5128E021-75F1-43D4-8C62-036DECDFA3CFQ35639039-3C8773B6-760A-4F6D-B31B-8D6F0BE30EBCQ37511553-4ACCF073-5E1F-48E8-945B-7CAB3A13A723Q39451283-0867C36D-DFAE-4E7D-B777-9960E73CA748Q39539848-ED4F500F-81D0-407B-A54C-B5A15B6252FCQ39627888-F4C07B27-E013-4967-820B-E852BD16241FQ41472497-BD04EF49-EC4E-49E4-A169-F146DC91D75FQ45610977-3EE9D1F3-51CB-4F8C-986E-CF36C552A09AQ51058177-1CC89078-6534-42D8-89EF-2622C4137FD0Q58321127-F3D4AADE-B211-4F2D-9733-F7A793837943Q68232274-D2C03DF3-B91F-4803-8666-B9FA07BE5A0AQ69110851-75897079-217D-4C63-9D36-64060993CC16Q72459373-D6C52920-F214-4A7B-94D8-A9EFCE1B0882
P50
description
researcher ORCID ID = 0000-0002-1226-9870
@en
name
Jan-Åke Liljeqvist
@ast
Jan-Åke Liljeqvist
@en
Jan-Åke Liljeqvist
@nl
type
label
Jan-Åke Liljeqvist
@ast
Jan-Åke Liljeqvist
@en
Jan-Åke Liljeqvist
@nl
prefLabel
Jan-Åke Liljeqvist
@ast
Jan-Åke Liljeqvist
@en
Jan-Åke Liljeqvist
@nl
P31
P496
0000-0002-1226-9870